| Product dosage: 250mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 90 | $0.45 | $40.13 (0%) | 🛒 Add to cart |
| 120 | $0.37 | $53.51 $44.15 (18%) | 🛒 Add to cart |
| 180 | $0.30 | $80.27 $54.18 (33%) | 🛒 Add to cart |
| 360 | $0.22
Best per pill | $160.54 $79.27 (51%) | 🛒 Add to cart |
| Product dosage: 500mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $0.72 | $43.14 (0%) | 🛒 Add to cart |
| 90 | $0.55 | $64.72 $49.17 (24%) | 🛒 Add to cart |
| 120 | $0.46 | $86.29 $55.19 (36%) | 🛒 Add to cart |
| 180 | $0.38 | $129.43 $68.23 (47%) | 🛒 Add to cart |
| 270 | $0.32 | $194.15 $86.29 (56%) | 🛒 Add to cart |
| 360 | $0.29
Best per pill | $258.87 $104.35 (60%) | 🛒 Add to cart |
| Product dosage: 750mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $1.97 | $59.20 (0%) | 🛒 Add to cart |
| 60 | $1.39 | $118.40 $83.28 (30%) | 🛒 Add to cart |
| 90 | $1.18 | $177.60 $106.36 (40%) | 🛒 Add to cart |
| 120 | $1.09 | $236.80 $130.44 (45%) | 🛒 Add to cart |
| 180 | $0.99 | $355.19 $177.60 (50%) | 🛒 Add to cart |
| 360 | $0.88
Best per pill | $710.39 $318.07 (55%) | 🛒 Add to cart |
Synonyms | |||
Similar products
More info:
cipro
Ciprofloxacin, commonly referred to as Cipro, is a broad-spectrum fluoroquinolone antibiotic that has been a cornerstone in treating bacterial infections since its introduction in the 1980s. It works by inhibiting bacterial DNA gyrase and topoisomerase IV, enzymes critical for DNA replication, transcription, and repair. Available in oral tablets, intravenous formulations, and ophthalmic/otic solutions, Cipro is prescribed for a wide range of infections, including urinary tract infections, respiratory tract infections, and gastrointestinal infections, particularly when caused by multidrug-resistant pathogens.
ciprodex ophthalmic solution
Ciprodex ophthalmic solution combines ciprofloxacin, a potent fluoroquinolone antibiotic, with dexamethasone, a powerful corticosteroid, creating what we in ophthalmology call “the workhorse” for serious anterior segment infections. I remember first encountering this formulation during my residency when a construction worker presented with a metal foreign body embedded in his cornea - the classic recipe for a devastating bacterial ulcer with significant inflammation. We needed something that could penetrate tissue effectively while controlling the inflammatory cascade, and Ciprodex delivered where single-agent drops failed.
Ciloxan Ophthalmic Solution: Effective Bacterial Conjunctivitis Treatment - Evidence-Based Review
Ciloxan ophthalmic solution is a sterile, preservative-free topical medication containing ciprofloxacin hydrochloride as the active ingredient. It’s formulated specifically for ocular use, providing broad-spectrum antibacterial coverage against common pathogens responsible for eye infections. The solution comes in a convenient dropper bottle that allows precise dosing while maintaining sterility throughout the treatment course. 1. Introduction: What is Ciloxan Ophthalmic Solution? Its Role in Modern Ophthalmology Ciloxan ophthalmic solution represents a cornerstone in ocular anti-infective therapy, specifically formulated to address bacterial infections of the eye and surrounding tissues.
Ciplox: Potent Broad-Spectrum Antibacterial Therapy - Evidence-Based Review
Ciprofloxacin, commonly encountered in clinical practice under various brand names including Ciplox, represents a cornerstone fluoroquinolone antibiotic with a broad spectrum of activity against both Gram-positive and Gram-negative bacteria. Its development marked a significant advancement in antimicrobial therapy, particularly for complex infections where other classes had begun to falter due to rising resistance patterns. In hospital formularies and outpatient settings alike, it’s often a go-to for clinicians dealing with everything from stubborn urinary tract infections to more systemic issues, though its use has become more nuanced over the years due to safety profile considerations.
clozaril
Clozaril represents one of the most significant advances in treatment-resistant schizophrenia pharmacotherapy, yet remains widely misunderstood outside psychiatric specialty circles. As an atypical antipsychotic with a unique receptor profile, it demands respect for both its remarkable efficacy and substantial safety considerations. Clozaril: Superior Efficacy in Treatment-Resistant Schizophrenia - Evidence-Based Review 1. Introduction: What is Clozaril? Its Role in Modern Medicine Clozaril (clozapine) stands as the prototype atypical antipsychotic medication, distinguished by its dibenzodiazepine chemical structure and unique pharmacological properties.
Esbriet: Slowing Disease Progression in Idiopathic Pulmonary Fibrosis - Evidence-Based Review
Pirfenidone, marketed under the brand name Esbriet, represents a significant advancement in the management of idiopathic pulmonary fibrosis (IPF). As an orally administered antifibrotic agent, it targets the underlying pathological processes of this progressive and ultimately fatal lung disease. Unlike traditional approaches that merely addressed symptoms, Esbriet works at the molecular level to slow disease progression—a paradigm shift in IPF management that has changed how we approach this challenging condition in clinical practice.
floxin
Ofoxacin, marketed under the brand name Floxin among others, is a synthetic broad-spectrum fluoroquinolone antibacterial agent. It’s been around since the 1980s, and honestly, we’ve had a real love-hate relationship with it in clinical practice. You remember those days, right? When a patient came in with a nasty UTI or a stubborn ear infection that wasn’t responding to first-line treatments, Floxin was often our go-to. It worked, often spectacularly well, but we’ve learned so much about its risk profile since then.
levaquin
Levofloxacin, commonly known by its brand name Levaquin, is a synthetic broad-spectrum fluoroquinolone antibiotic. It’s been a workhorse in our infectious disease arsenal for decades, particularly for tough respiratory, skin, and urinary tract infections where other agents fail. I remember when it first came out, it felt like we finally had a real weapon against some of the nastier bugs we’d see in the hospital. But its story is a complex one, marked by both remarkable efficacy and significant safety debates that have shaped its use over the years.
levoflox
Levoflox, a third-generation fluoroquinolone antibiotic, represents one of the most significant advances in antimicrobial therapy over the past two decades. As the L-isomer of ofloxacin, this synthetic broad-spectrum agent demonstrates enhanced potency against both Gram-positive and Gram-negative pathogens while maintaining the favorable pharmacokinetic profile characteristic of its class. What began as a structural optimization project at Daiichi Pharmaceutical Company in the early 1990s has evolved into a cornerstone agent for treating complicated infections across multiple organ systems.